Patient-reported Outcomes of Short-term Intra-articular Hyaluronic Acid for Osteoarthritis of the Knee: A Consecutive Case Series

Background Supartz FX (Seikagaku Corp., Tokyo, Japan) has been investigated as a therapeutic for knee osteoarthritis (OA) due to its claimed preservation of viscoelastic joint properties and improvement in pain and physical function. The US prescribing information suggests patients may experience be...

Descripción completa

Detalles Bibliográficos
Autores principales: Gusho, Charles A, Jenson, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Pain Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701911/
https://www.ncbi.nlm.nih.gov/pubmed/31453043
http://dx.doi.org/10.7759/cureus.4972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701911/
https://www.ncbi.nlm.nih.gov/pubmed/31453043
http://dx.doi.org/10.7759/cureus.4972

Ejemplares similares